Accelerated approval for Genglycos (pariglasgene brecaparvovec), a gene therapy for GSDIa.
Why this matters
GSDIa forces constant fear of low blood sugar and lifelong dietary control. A first approved therapy means the disease is no longer something medicine could only manage by hand.
WHO confirmed the country interrupted indigenous malaria transmission and held it long enough to earn certification.
Why this matters
Malaria still kills hundreds of thousands a year. A whole country proving it can end transmission is a template — and a permanent win for every child born there from now on.
SL2T powers new sign-language features so signed speech can become text for people who need it.
Why this matters
Hundreds of millions of people use sign languages. Turning signed speech into text without a human intermediary is access — to services, work, and conversation — that used to require another person in the room.
Orzeyful (oveporexton) tablets were approved for adults with narcolepsy type 1.
Why this matters
Narcolepsy type 1 steals wakefulness in the middle of ordinary life. A drug aimed at the full symptom set — not just one slice — is how people get days back.
Accelerated approval for Tudriqev (vusolimogene oderparepvec), a genetically modified oncolytic virus therapy.
Why this matters
When melanoma stops responding to standard care, options collapse fast. A new approved viral immunotherapy is another path for people who had run out of them.
Aletta was authorized as a robotic phlebotomy device that draws blood from the arm autonomously.
Why this matters
Blood draws fail often when veins are hard to find, and skilled phlebotomists are scarce. A machine that can take the stick expands who can get lab work done reliably.